Official update detected
Medical device registration guidance updated
MedXtion helps medical device teams detect official regulatory changes, understand the impact, and turn them into traceable next steps.
Medical device registration guidance updated
Updates are scattered across authorities, standards bodies and public institutes. The real work starts after discovery: deciding what changed, what it affects and who needs to act.
Regulatory updates are published across multiple official sources.
Repetitive checking on official websites, inboxes, newsletters, and professional networks.
Updates are detected, but struggle to translate them into timely, accountable internal actions.
MedXtion connects official-source monitoring, AI-assisted impact mapping and a searchable decision trail in one focused workflow.
Monitor curated official regulatory sources.
Triage impact, risk and urgency.
Assign owners and track next steps.
The objective is not to replace regulatory evaluation. It is to give specialists better monitoring and triage to focus on the decision and implementation.
Spend less time repeating website checks and consolidating fragmented signals.
Move faster from detection to a structured view of risk, products and functions.
Preserve a defensible thread from official source to internal owner and action.
Reduce missed deadlines, delayed launches and avoidable compliance exposure.
A focused workflow that keeps each regulatory decision connected to its official source.
Designed for small and mid-sized medical device companies with international market access.
Pilot module
Planned expansion
Planned expansion
Practical introductions to medical device regulatory monitoring and impact assessment across priority markets.
Build a source-controlled process from surveillance through accountable action.
EUROPEAN UNIONConnect changing guidance and requirements to technical documentation and QMS controls.
CHINAMonitor NMPA and related authorities with a structured applicability review.
BRAZILTrack official notices and assess portfolio, registration, and vigilance impact.
WORKFLOWTurn a new source into a reviewable product, process, and evidence decision.
We’re speaking with regulatory and quality professionals who manage China market access. Join the early-access list for future pilot testing.
“Regulatory teams do not need more noise. They need an evaluation system with traceable actions.”